Загрузка...
Evaluation of a 12‐Hour Sustained‐Release Acetaminophen (Paracetamol) Formulation: A Randomized, 3‐Way Crossover Pharmacokinetic and Safety Study in Healthy Volunteers
Acetaminophen (paracetamol) is a first‐line treatment for mild and moderate pain. A twice‐daily sustained‐release (SR) formulation may be more convenient for chronic users than standard immediate‐release (IR) acetaminophen. This randomized, 3‐way crossover study evaluated pharmacokinetics and safety...
Сохранить в:
| Опубликовано в: : | Clin Pharmacol Drug Dev |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6084333/ https://ncbi.nlm.nih.gov/pubmed/28816026 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.367 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|